tiprankstipranks
Pieris Pharmaceuticals (PIRS)
NASDAQ:PIRS

Pieris Pharmaceuticals (PIRS) Income Statement

583 Followers

Pieris Pharmaceuticals Income Statement

Last quarter (Q3 2023), Pieris Pharmaceuticals's total revenue was $19.52M, an increase of 263.50% from the same quarter last year. In Q3, Pieris Pharmaceuticals's net income was $-10.75M. See Pieris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 49.05M$ 42.32M$ 25.90M$ 3.69M$ 29.32M$ 46.28M
Cost of Revenue
------
Gross Profit
$ 48.97M$ 42.32M$ 25.90M$ 3.69M--
Operating Expense
$ 14.51M$ 58.65M$ 69.38M$ 83.25M$ 63.24M$ 73.44M
Operating Income
$ -8.05M$ -16.33M$ -43.47M$ -79.56M$ -33.92M$ -27.16M
Net Non Operating Interest Income Expense
$ 279.00K$ 1.85M$ 721.00K$ 4.00K$ 511.00K$ 1.71M
Other Income Expense
$ -19.84M$ -3.85M$ -9.91M$ -33.82M$ -3.66M$ -26.00K
Pretax Income
$ 8.12M$ -24.54M$ -33.28M$ -45.74M$ -37.07M$ -25.47M
Tax Provision
----$ 164.00K$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 4.80M$ -24.54M$ -33.28M$ -45.74M$ -37.23M$ -28.30M
Basic EPS
$ -0.35$ -0.27$ -0.45$ -0.71$ -0.68$ -0.56
Diluted EPS
$ -0.03$ -0.27$ -0.45$ -0.71$ -0.68$ -0.56
Basic Average Shares
$ 335.18M$ 90.06M$ 74.17M$ 64.55M$ 54.48M$ 50.63M
Diluted Average Shares
$ 261.20M$ 90.06M$ 74.17M$ 64.55M$ 54.48M$ 50.63M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 14.51M$ 72.57M$ 69.38M$ 83.25M$ 63.24M$ 73.44M
Net Income From Continuing And Discontinued Operation
$ -28.06M$ -24.54M$ -33.28M$ -45.74M$ -37.23M$ -25.47M
Normalized Income
$ 9.54M$ 8.44M$ -26.29M-$ -37.23M$ -25.47M
Interest Expense
------
EBIT
$ 23.07M$ -24.54M$ -33.28M$ -45.74M$ -33.92M$ -27.16M
EBITDA
$ 25.72M$ -22.64M$ -30.51M$ -43.28M$ -31.79M$ -26.12M
Currency in USD

Pieris Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis